Susan Wyrick
2013
In 2013, Susan Wyrick earned a total compensation of $431.9K as Principal Accounting Officer and Vice President, Finance at OncoGenex Pharmaceuticals, a 60% increase compared to previous year.
Compensation breakdown
Bonus | $5,000 |
---|---|
Non-Equity Incentive Plan | $40,000 |
Option Awards | $77,656 |
Salary | $200,000 |
Stock Awards | $109,248 |
Total | $431,904 |
Wyrick received $200K in salary, accounting for 46% of the total pay in 2013.
Wyrick also received $5K in bonus, $40K in non-equity incentive plan, $77.7K in option awards and $109.2K in stock awards.
Rankings
In 2013, Susan Wyrick's compensation ranked 9,821st out of 12,286 executives tracked by ExecPay. In other words, Wyrick earned more than 20.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,821 out of 12,286 | 20th |
Division Manufacturing | 3,651 out of 4,612 | 21st |
Major group Chemicals And Allied Products | 1,158 out of 1,462 | 21st |
Industry group Drugs | 903 out of 1,156 | 22nd |
Industry In Vitro and In Vivo Diagnostic Substances | 39 out of 56 | 30th |
Source: SEC filing on April 24, 2014.
Wyrick's colleagues
We found three more compensation records of executives who worked with Susan Wyrick at OncoGenex Pharmaceuticals in 2013.